Marinus Pharmaceuticals, Inc. Share Price Deutsche Boerse AG
Equities
61Y
US56854Q2003
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 EUR | -2.48% | -2.48% | -87.90% |
Sales 2024 * | 39.35M 36.35M 3.28B | Sales 2025 * | 58.17M 53.73M 4.84B | Capitalization | 70.86M 65.45M 5.9B |
---|---|---|---|---|---|
Net income 2024 * | -120M -111M -9.99B | Net income 2025 * | -77M -71.12M -6.41B | EV / Sales 2024 * | -1.44 x |
Net cash position 2024 * | 127M 118M 10.61B | Net cash position 2025 * | 54.53M 50.37M 4.54B | EV / Sales 2025 * | 0.28 x |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-1.24
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -1.24% | ||
1 week | -2.48% | ||
Current month | -7.81% | ||
1 month | -13.24% | ||
3 months | -86.51% | ||
6 months | -78.55% | ||
Current year | -87.90% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/18/05 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12/21/12 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06/19/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01/08/01 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/18/05 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12/19/12 |
Date | Price | Change |
---|---|---|
23/24/23 | 1.18 | -2.48% |
22/24/22 | 1.21 | -1.63% |
21/24/21 | 1.23 | +1.65% |
20/24/20 | 1.21 | +2.54% |
17/24/17 | 1.18 | -2.48% |
Delayed Quote Deutsche Boerse AG, May 23, 2024 at 11:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.74% | 723B | |
+32.22% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.60% | 244B | |
+9.77% | 208B | |
-5.15% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock